Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE-Reference-Cited by-同舟云学术

Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE

Published:2012-01 Issue:1 Volume:12 Page:257-270
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Seavey Matthew M.,Lu Lily D.,Stump Kristine L.,Wallace Nate H.,Ruggeri Bruce A.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference49 articles.

1. The geoepidemiology of systemic lupus erythematosus;Borchers;Autoimmun Rev,2010

2. A new hypothesis of the possible mechanisms of gender differences in systemic lupus erythematosus;Sekigawa;Clin Exp Rheumatol,2010

3. Update on the management of lupus nephritis: let the treatment fit the patient;Bertsias;Nat Clin Pract Rheumatol,2008

4. New immunosuppresor strategies in the treatment of murine lupus nephritis;Alperovich;Lupus,2007

5. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential;Zhao;Arthritis Rheum,2005

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities;Research and Reports in Urology;2023-07

2. Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline;Drugs;2023-03-27

3. Aberrant B Cell Signaling in Autoimmune Diseases;Cells;2022-10-27

4. Plasma Cell Directed Therapy for Immune Thrombotic Thrombocytopenic Purpura (iTTP);Transfusion Medicine Reviews;2022-10

5. Enantioselective synthesis of cyclic α-aminoboronates via copper-catalyzed dearomative borylation of 4-quinolinols;Chemical Communications;2022